<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02984618</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE: 60693416.0.0000.5558</org_study_id>
    <nct_id>NCT02984618</nct_id>
  </id_info>
  <brief_title>Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial</brief_title>
  <official_title>Gabriel Guimaraes: Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brasilia University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brasilia University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Recently sphenopalatine block emerged as an alternative to epidural blood patch
      for post dural puncture headache but the investigators do not know if it has significant
      efficacy when compared to epidural blood patch. Method: randomized trial where patients will
      randomly receive either sphenopalatine block or epidural blood patch. Pain relief to no pain
      or low intensity pain will be the main outcome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Recently sphenopalatine block emerged as an alternative to epidural blood patch
      for post dural puncture headache but the investigators do not know if it has significant
      efficacy when compared to epidural blood patch. Method: randomized clinical trial where
      patients with moderate to severe post dural puncture pain will randomly receive either
      sphenopalatine block or epidural blood patch. Pain relief to no pain or low intensity pain
      will be the main outcome. Pain recurrence, survival without pain and side effects (tinitus,
      low back pain, new dural puncture, sore throat) will be secondary outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>Pain reduction to no pain or low pain within 30 minutes of the intervention.</time_frame>
    <description>Pain assessed by categorical verbal scale (no pain, low pain, moderate pain or severe pain) 30 minutes after the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tinitus</measure>
    <time_frame>Incidence (dichotomic) of tinutus within 24 hours after the procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low back pain</measure>
    <time_frame>Incidence (dichotomic) of low back pain within 24 hours after the procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sore throat</measure>
    <time_frame>Incidence (dichotomic) of sore throat within 24 hours after the procedure.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain relief survival</measure>
    <time_frame>Incidence of new headache onset during the first two weeks</time_frame>
    <description>Patients will be contacted for the first two weeks for monitoring new headache onsets.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Post-Dural Puncture Headache</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive sphenopalatine ganglion block with ropivacaine 0.375% 3ml on each side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive classic epidural blood patch with 20ml of autologous blood</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sphenopalatine ganglion block</intervention_name>
    <description>Cotton- tipped applicators inserted up through the nose followed by infusion of ligdocaine through the applicators.</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural blood patch</intervention_name>
    <description>Autologous sterile blood (20ml) will be infused in the lombar epidural space.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic criteria for post dural puncture headache

          -  Moderate to severe post dural puncture headache

        Exclusion Criteria:

          -  Procedure failures: new dural puncture on epidural blood patch trial, unable to find
             epidural space, intolerance to insertion of nasal swabs.

          -  Follow up loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel MN Guimaraes, MsC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade de Brasilia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel MN Guimaraes, Md, Msc</last_name>
    <phone>+5561996455997</phone>
    <email>gabrielmng@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitário de Brasilia</name>
      <address>
        <city>Brasilia</city>
        <state>Distrito Federal</state>
        <zip>70000000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel MN Guimarães, MD, MsC</last_name>
      <phone>+5561996455997</phone>
      <email>gabrielmng@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gabriel MN Guimarães, Md, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2016</study_first_submitted>
  <study_first_submitted_qc>December 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2016</study_first_posted>
  <last_update_submitted>December 12, 2016</last_update_submitted>
  <last_update_submitted_qc>December 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brasilia University Hospital</investigator_affiliation>
    <investigator_full_name>Gabriel Magalhaes Nunes Guimaraes</investigator_full_name>
    <investigator_title>Substitute professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

